Tregs move one step closer to the clinic - Regeneron is partnering with Sonoma ( founded by Bluestone, Rudensky, Ramsdell & Tang) targeting ulcerative colitis, Crohn's and "two other undisclosed indications".

https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sonoma-biotherapeutics-announce-collaboration?utm_campaign=SONOMA+COLLABORATION&utm_source=Social+&utm_medium=LinkedIn